Novel Coronavirus: Clinical Trials

This letter from the Chief Medical Officers asks that every effort be made to enrol COVID-19 patients in the national priority clinical trials (PRINCIPLE, RECOVERY, REMAP-CAP, and others) to enable the gathering of reliable evidence across the whole disease spectrum.


Medicines and Healthcare products Regulatory Agency